Japan
In this section you will find Country Japan market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities of value to your organization.
-
Japanese Generic Market Forecast to 2013
$800.00Published by RNCOS on Mar 1st, 2011Generic drugs are produced and distributed without patent protection and marketed after the expiry date of patent or other rights. Usually, generic drugs are as effective as their master drugs... Learn More -
OTC Pharmaceuticals - Global Group of Eight (G8) Industry Guide
$1,495.00Published by Datamonitor on Nov 1st, 2010Datamonitor’s OTC Pharmaceuticals - Global Group of Eight (G8) Industry Guide is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry in each of the G8... Learn More -
Pharmaceutical M&A in the Asia-Pacific Region - India and China drive regional activity but Japan still dominates high value transactions
$7,600.00Published by Datamonitor on Aug 19th, 2010Expanding healthcare coverage in emerging Asia-Pacific markets, rapid economic growth and burgeoning middle classes are attracting foreign M&A as companies attempt to offset future losses from the looming... Learn More -
Pharmaceuticals - Global Group of Eight (G8) Industry Guide
$1,495.00Published by Datamonitor on Apr 27th, 2010Datamonitor’s Pharmaceuticals - Global Group of Eight (G8) Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in each of the G8 (United States... Learn More -
Pharmaceuticals: Japan Industry Guide
$995.00Published by Datamonitor on Feb 17th, 2010Datamonitor’s Pharmaceuticals: Japan Industry Guide is an essential resource for top-level data and analysis covering the Japan Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual... Learn More -
Pharmaceuticals: Japan Industry Guide
$740.00Published by Datamonitor on Apr 8th, 2009Pharmaceuticals: Japan Industry Guide is an essential resource for top-level data and analysis covering the Japan Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis with distinct chapters for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals. Learn More -
Personal Hygiene/ Personal Care: Japan Industry Guide
$2,035.00Published by Datamonitor on Apr 8th, 2009This report is an essential resource for top-level data and analysis covering the Japan Personal Hygiene/ Personal Care industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. Learn More -
The Japanese Pharmaceutical Market 2008-2023
$2,461.00Published by Visiongain on Oct 10th, 2008This report examines Japanese pharmaceutical market critically, through a comprehensive review of available information. Sources include in-depth interviews, primary research, industrial databases, commercial news, in-house reports and economic research. Learn More -
World Gastrointestinal Disorders Market 2008-2023
$2,461.00Published by Visiongain on Oct 10th, 2008This report examines the GI market critically through detailed analysis of market leaders and new developments, interviews and questionaires with industry players, plus commercial databases, company reports and business/industry news. Learn More -
Pharmaceuticals in Japan
$250.00Published by Datamonitor on Dec 17th, 2007Pharmaceuticals in Japan industry profile is an essential resource for top-level data and analysis covering the pharmaceuticals industry. Learn More -
The Pharmaceutical Company Outlook to 2011: Financial and Strategic Analysis of the Sales Outlook for Big Pharma, Mid Pharma, Japan Pharma and Biotech
$7,600.00Published by Datamonitor on Dec 21st, 2006Based on an analysis of 46 companies and 1,000+ products, Datamonitor forecasts that pharmaceutical industry ethical sales will increase at a modest 4.9% CAGR 200511. However, behind this industry average figure there are strategic segments of the market that offer double-digit growth rates through barriers against generic competition and the opportunity for aggressive indication broadening. Learn More -
Pricing and Reimbursement in Japan: Costly healthcare system inefficiencies increase the focus on healthcare cost containment
$3,800.00Published by Datamonitor on Nov 9th, 2006The government has relied on simple P&R tools to contain rising healthcare costs and provide a reasonable level of healthcare. However, factors such as a healthier elderly population are masking healthcare system inefficiencies, boosting healthcare costs and increasing the focus on cost containment. Although the rise in drug spending is slowing down, it remains a visible cost containment target. Learn More -
Japanese Pharmaceutical Market, 2006-2011
$2,461.00Published by Visiongain on Jan 24th, 2006The Japanese pharmaceutical market is the second largest individual market and with sales of $60 billion constitutes approximately 11% of the world market. However, it is a market that frustrates the major pharmaceutical companies as it is growing at a significantly lower rate of growth... Learn More -
The eHealth Market in Japan: Optimizing eHealth Tools for Reaching Consumers
$3,800.00Published by Datamonitor on Dec 2nd, 2005The Internet is becoming a major source of healthcare and treatment information in Japan. In fact, Datamonitor research shows that surveyed consumers in Japan spend the most time online compared to surveyed consumers in the US and Europe. Regional and personal factors have contributed to consumers` high adoption of the Internet and have created new demands for online tools and services. Learn More -
Japanese Pharma to 2010 - Imminent Transition Towards Globalization Necessary for Survival
$15,200.00Published by Datamonitor on Feb 22nd, 2005Dominated by domestic companies in the past, the Japanese pharmaceutical market is evolving, as regulatory changes stimulate direct western competition and generic penetration, and government cost containment measures restrict the market. The Japanese pharmaceutical companies must focus on rejuvenating their product offerings and strengthening their pipelines to drive global growth. Learn More
Japan
In this section you will find Country Japan market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities of value to your organization.
-
Japanese Generic Market Forecast to 2013
$800.00Published by RNCOS on Mar 1st, 2011Generic drugs are produced and distributed without patent protection and marketed after the expiry date of patent or other rights. Usually, generic drugs are as effective as their master drugs... Learn More -
OTC Pharmaceuticals - Global Group of Eight (G8) Industry Guide
$1,495.00Published by Datamonitor on Nov 1st, 2010Datamonitor’s OTC Pharmaceuticals - Global Group of Eight (G8) Industry Guide is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry in each of the G8... Learn More -
Pharmaceutical M&A in the Asia-Pacific Region - India and China drive regional activity but Japan still dominates high value transactions
$7,600.00Published by Datamonitor on Aug 19th, 2010Expanding healthcare coverage in emerging Asia-Pacific markets, rapid economic growth and burgeoning middle classes are attracting foreign M&A as companies attempt to offset future losses from the looming... Learn More -
Pharmaceuticals - Global Group of Eight (G8) Industry Guide
$1,495.00Published by Datamonitor on Apr 27th, 2010Datamonitor’s Pharmaceuticals - Global Group of Eight (G8) Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in each of the G8 (United States... Learn More -
Pharmaceuticals: Japan Industry Guide
$995.00Published by Datamonitor on Feb 17th, 2010Datamonitor’s Pharmaceuticals: Japan Industry Guide is an essential resource for top-level data and analysis covering the Japan Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual... Learn More -
Pharmaceuticals: Japan Industry Guide
$740.00Published by Datamonitor on Apr 8th, 2009Pharmaceuticals: Japan Industry Guide is an essential resource for top-level data and analysis covering the Japan Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis with distinct chapters for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals. Learn More -
Personal Hygiene/ Personal Care: Japan Industry Guide
$2,035.00Published by Datamonitor on Apr 8th, 2009This report is an essential resource for top-level data and analysis covering the Japan Personal Hygiene/ Personal Care industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. Learn More -
The Japanese Pharmaceutical Market 2008-2023
$2,461.00Published by Visiongain on Oct 10th, 2008This report examines Japanese pharmaceutical market critically, through a comprehensive review of available information. Sources include in-depth interviews, primary research, industrial databases, commercial news, in-house reports and economic research. Learn More -
World Gastrointestinal Disorders Market 2008-2023
$2,461.00Published by Visiongain on Oct 10th, 2008This report examines the GI market critically through detailed analysis of market leaders and new developments, interviews and questionaires with industry players, plus commercial databases, company reports and business/industry news. Learn More -
Pharmaceuticals in Japan
$250.00Published by Datamonitor on Dec 17th, 2007Pharmaceuticals in Japan industry profile is an essential resource for top-level data and analysis covering the pharmaceuticals industry. Learn More -
The Pharmaceutical Company Outlook to 2011: Financial and Strategic Analysis of the Sales Outlook for Big Pharma, Mid Pharma, Japan Pharma and Biotech
$7,600.00Published by Datamonitor on Dec 21st, 2006Based on an analysis of 46 companies and 1,000+ products, Datamonitor forecasts that pharmaceutical industry ethical sales will increase at a modest 4.9% CAGR 200511. However, behind this industry average figure there are strategic segments of the market that offer double-digit growth rates through barriers against generic competition and the opportunity for aggressive indication broadening. Learn More -
Pricing and Reimbursement in Japan: Costly healthcare system inefficiencies increase the focus on healthcare cost containment
$3,800.00Published by Datamonitor on Nov 9th, 2006The government has relied on simple P&R tools to contain rising healthcare costs and provide a reasonable level of healthcare. However, factors such as a healthier elderly population are masking healthcare system inefficiencies, boosting healthcare costs and increasing the focus on cost containment. Although the rise in drug spending is slowing down, it remains a visible cost containment target. Learn More -
Japanese Pharmaceutical Market, 2006-2011
$2,461.00Published by Visiongain on Jan 24th, 2006The Japanese pharmaceutical market is the second largest individual market and with sales of $60 billion constitutes approximately 11% of the world market. However, it is a market that frustrates the major pharmaceutical companies as it is growing at a significantly lower rate of growth... Learn More -
The eHealth Market in Japan: Optimizing eHealth Tools for Reaching Consumers
$3,800.00Published by Datamonitor on Dec 2nd, 2005The Internet is becoming a major source of healthcare and treatment information in Japan. In fact, Datamonitor research shows that surveyed consumers in Japan spend the most time online compared to surveyed consumers in the US and Europe. Regional and personal factors have contributed to consumers` high adoption of the Internet and have created new demands for online tools and services. Learn More -
Japanese Pharma to 2010 - Imminent Transition Towards Globalization Necessary for Survival
$15,200.00Published by Datamonitor on Feb 22nd, 2005Dominated by domestic companies in the past, the Japanese pharmaceutical market is evolving, as regulatory changes stimulate direct western competition and generic penetration, and government cost containment measures restrict the market. The Japanese pharmaceutical companies must focus on rejuvenating their product offerings and strengthening their pipelines to drive global growth. Learn More